See other companies on Welcome to the Jungle
PathAI
AI-powered pathology tools
- 201-500 employees
- Healthcare
- B2B
- Artificial Intelligence
- Big data
- Deep Tech
- SaaS
- MedTech
- West Fens, Boston, MA
Jump to section
Company mission
To improve patient outcomes with AI-powered pathology.
Our take
PathAI is a leader in the field of AI-powered pathology, dedicated to transforming patient outcomes by harnessing the power of AI. Its core mission revolves around enhancing the accuracy of diagnoses and the effectiveness of disease treatments, particularly in critical areas like cancer.
PathAI's pioneering spirit is evident through its breakthroughs, exemplified by innovations such as the AIM-HER2 Breast Cancer algorithm. This tool automates HER2 scoring and introduces a novel approach with additive multiple instance learning (aMIL) heatmaps, offering insights into scoring mechanisms. Additionally, PathAI's PathExplore panel of human interpretable features (HIFs) fosters collaborative research, thus enhancing understanding of the tumor microenvironment.
As the company moves forward, it is poised to continue shaping the landscape of AI-powered pathology, driving advancements in medical research, diagnostics, and drug development, while upholding its central mission to improve patient well-being.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Comprehensive Health Plans
- Paid Time Off & Paid Holidays
- Wellness Benefits
- 401(k) Program
- Parental Leave
Company values
- Patient First: We embody a patient first mindset with everything we do and are committed to meeting the needs of our customers to improve patient outcomes
- Accountability: We set out to accomplish the tasks we commit to and take responsibility for our work, and our actions
- Team: We are One PathAI, all working towards the same goal. We trust our teammates and count one each other to get the job done
- Humility: We know all that we do matters, big and small. We value openness, we are accepting of others, and are curious to learn from each other
- All In: We are all passionate about our mission and our passion pushes us to be better every day
Funding (last 2 of 7 rounds)
May 2021
$165m
SERIES C
Nov 2019
$15m
SERIES B
Total funding: $258.6m
This company has top investors
Leadership
Andrew Beck
(CEO)Graduated from Stanford University with a PhD in Biomedical Informatics. Previously worked at Harvard Medical School as a Professor of Pathology.
Aditya Khosla
(Advisor)Graduated from the Massachusetts Institute of Technology with a PhD in Computer Science. They now serve as the CTO at Iterative Health.
Articles
Jobs (2)
Software Engineering